Leukothea Ioakimidis

Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180

Steven P. Treon, Leukothea Ioakimidis, Jacob D. Soumerai et al. · Journal of Clinical Oncology · 2009 · 290 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Benchmarking the Reliability of QikProp. Correlation between Experimental and Predicted Values

Leukothea Ioakimidis, Loizos Thoukydidis, Amin Mirza et al. · QSAR & Combinatorial Science · 2007 · 287 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside Analogs

Xavier Leleu, Jacob D. Soumerai, Aldo M. Roccaro et al. · Journal of Clinical Oncology · 2008 · 185 citations · Full text

Medicine, Hematology, Oncology +16

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis et al. · Blood · 2008 · 147 citations · Full text

Life Sciences, Hematology, Immunology +8

Thalidomide and rituximab in Waldenstrom macroglobulinemia

Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan et al. · Blood · 2008 · 143 citations · Full text

Medicine, Hematology, Pharmacotherapy +6